Suma Ramadas, PhDMedical Affairs
Daniel SontupeMarket Access
David LinetskyPoint-of-Care Marketing
Brenda SnowAuthentic Patient Voice
Paul TheisenPatient Acquisition
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Liz KaneImpactful Strategy
Joey CohenMedication Adherence
Matthew DurhamOmnidynamic Marketing
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
Amy GilesIncreasing Engagement
Investigational therapy crizanlizumab (SEG101, formerly SelG1) approximately doubled the time to first on-treatment sickle ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email